AbbVie Says Rivals' Rinvoq Generics Infringe 34 Patents
AbbVie has lodged 136 patent infringement claims against Sandoz and a handful of other pharmaceutical companies, accusing them of infringing dozens of AbbVie's patents with their proposed generic versions of its...To view the full article, register now.
Already a subscriber? Click here to view full article